Next Article in Journal
Spasmolytic Activity of 1,3-Disubstituted 3,4-Dihydroisoquinolines
Previous Article in Journal
How General and Inflammatory Status Impacts on the Prognosis of Patients Affected by Lung Cancer: State of the Art
Previous Article in Special Issue
Combination Therapy for Sustainable Fish Oil Products: Improving Cognitive Function with n-3 PUFA and Natural Ingredients
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Evaluation of Neuroinflammatory Contribution to Neurodegeneration in LRRK2 Drosophila Models

1
Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy
2
Department Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy
3
Department of Agricultural Sciences, University of Sassari, 07100 Sassari, Italy
*
Author to whom correspondence should be addressed.
Biomedicines 2024, 12(7), 1555; https://doi.org/10.3390/biomedicines12071555
Submission received: 5 June 2024 / Revised: 4 July 2024 / Accepted: 9 July 2024 / Published: 12 July 2024
(This article belongs to the Special Issue Pharmacological Targets for Neuroinflammation)

Abstract

Pathological mutations in the LRRK2 gene are the major genetic cause of Parkinson’s disease (PD). Although several animal models with either LRRK2 down- or over-expression have been developed, the physiological function of LRRK2 remains elusive. LRRK2 is constitutively expressed in various tissues including neurons and glial cells, but importantly, it is expressed at low levels in dopaminergic neurons, further contributing to the cryptic function of LRRK2. Significant levels of LRRK2 protein and mRNA have been detected in peripheral blood mononuclear cells, lymph nodes, the spleen, and primary microglia, strongly suggesting the contribution of inflammatory cells to neuronal degeneration. In this research article, using Drosophila LRRK2 models, we were able to demonstrate a significant contribution of glial cells to the LRRK2 pathological phenotype. Furthermore, in Drosophila, neurodegeneration is associated with a significant and important increase in specific inflammatory peptides. Finally, levetiracetam, a compound widely used in human therapy to treat epilepsy, was able to rescue both neuronal degeneration and neuroinflammation.
Keywords: LRRK2; glial cells; levetiracetam; neuroinflammation; Parkinson’s disease LRRK2; glial cells; levetiracetam; neuroinflammation; Parkinson’s disease

Share and Cite

MDPI and ACS Style

Nguyen, H.N.; Galleri, G.; Rassu, A.; Ciampelli, C.; Bernardoni, R.; Galioto, M.; Albani, D.; Crosio, C.; Iaccarino, C. Evaluation of Neuroinflammatory Contribution to Neurodegeneration in LRRK2 Drosophila Models. Biomedicines 2024, 12, 1555. https://doi.org/10.3390/biomedicines12071555

AMA Style

Nguyen HN, Galleri G, Rassu A, Ciampelli C, Bernardoni R, Galioto M, Albani D, Crosio C, Iaccarino C. Evaluation of Neuroinflammatory Contribution to Neurodegeneration in LRRK2 Drosophila Models. Biomedicines. 2024; 12(7):1555. https://doi.org/10.3390/biomedicines12071555

Chicago/Turabian Style

Nguyen, Hoai Nam, Grazia Galleri, Antonio Rassu, Cristina Ciampelli, Roberto Bernardoni, Manuela Galioto, Diego Albani, Claudia Crosio, and Ciro Iaccarino. 2024. "Evaluation of Neuroinflammatory Contribution to Neurodegeneration in LRRK2 Drosophila Models" Biomedicines 12, no. 7: 1555. https://doi.org/10.3390/biomedicines12071555

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop